Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 128.00 | |
5 mg | In stock | $ 320.00 | |
10 mg | In stock | $ 470.00 | |
25 mg | In stock | $ 772.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,460.00 | |
500 mg | In stock | $ 2,920.00 |
Description | Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris. |
Targets&IC50 | Ca2+ channel:0.33 µM |
In vivo | Elgodipine (64 micrograms/kg; i.v.; 22 patients) significantly decreased systemic vascular resistance as well as systolic and diastolic blood pressure, while increasing cardiac output and stroke volume. Heart rate was not affected by elgodipine, either at rest or during exercise.[1] |
Molecular Weight | 524.58 |
Formula | C29H33FN2O6 |
CAS No. | 119413-55-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (104.85 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Elgodipine 119413-55-7 inhibitor inhibit